Glucose meter issue shows split in EU regulatory thinking
This article was originally published in Clinica
The UK's Medical Devices Agency has concluded that there is no reason to remove from the UK market the 12 blood glucose meters that were suspended from the French market in March 1999.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.